Effect of vasoactive intestinal peptide (VIP) on cytokine production and expression of VIP receptors in thymocyte subsets

Regulatory Peptides

Volumn 72, Issue 1, 1997, Pages 41-54

  Xin, Zhicheng ^a,b   Jiang, Xiaoming ^a,b   Wang, Hong Ying ^a   Denny, Thomas N ^c   Dittel, Bonnie N ^d   Ganea, Doina ^a  

^a RUTGERS UNIVERSITY   (United States)

^b RUTGERS UNIVERSITY   (United States)

^c RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^d YALE UNIVERSITY   (United States)

Author keywords

T cell lines; Thymocyte subsets; Vasoactive intestinal peptide

Indexed keywords

VASOACTIVE INTESTINAL POLYPEPTIDE; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR;

ARTICLE; CELL MATURATION; CELL SUBPOPULATION; LYMPHOID CELL LINE; PRIORITY JOURNAL; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; T LYMPHOCYTE; THYMOCYTE;

ANIMALS; BASE SEQUENCE; CALCIMYCIN; CELLS, CULTURED; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; INTERLEUKIN-2; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, INTERLEUKIN-2; RECEPTORS, VASOACTIVE INTESTINAL PEPTIDE; RNA, MESSENGER; SIGNAL TRANSDUCTION; T-LYMPHOCYTE SUBSETS; TETRADECANOYLPHORBOL ACETATE; TUMOR CELLS, CULTURED; VASOACTIVE INTESTINAL PEPTIDE;

EID: 0030731555     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-0115(97)01028-8     Document Type: Article

References (60)

1. Bellinger D.L., Lorton D., Romano T.D., Olsdrowska J.A., Felten S.Y., Felten D.L. Neuropeptides and immunopeptides: messengers in a neuroimmune axis. Ann. N.Y. Acad. Sci. 594:1990;17-33.
2. Blalock JE. Production of peptide hormones and neurotransmitters by the immune system. In: Blalock JE, editor. Neuroimmunoendocrinology: Chemical Immunology, vol. 52, 2nd ed. Karger:Basel, 1992:1-19.
3. Blalock J.E. The syntax of immune neuroendocrine communication. Immunol. Today. 15:1994;504-511.
4. Carr DJJ. Neuroendocrine peptide receptors on cells of the immune system. In Blalock JE, editor, Neuroimmunoendocrinology: Chemical Immunology, vol. 52, 2nd ed. Karger:Basel, 1992:49-83.
5. Dardenne M., Savino W. Control of thymus physiology by peptide hormones and neuropeptides. Immunol. Today. 15:1994;518-523.
6. Savino W., Dardenne M. Immune-neuroendocrine interactions. Immunol. Today. 16:1995;318-322.
7. Martens H., Goxe B., Geenen V. The thymic repertoire of neuroendocrine selfantigens: physiological implications in T-cell life and death. Immunol. Today. 17:1996;249-254.
8. Bellinger D.L., Lorton D., Brouxhon S., Felten S., Felten D.L. The significance of vasoactive intestinal polypeptide (VIP) in immunomodulation. Adv. Neuroimmunol. 6:1996;5-27.
9. Gomariz R.P., Lorenzo M.J., Caciedo L., Vicente A., Zapata A.G. Demonstration of IR-VIP and IR-SOM in rat thymus. Brain Behav Immun. 4:1991;151-161.
10. Gomariz R.P., Delgado M., Naranjo J.R., Mellstrom B., Tormo A., Mata F., Leceta J. VIP gene expression in rat thymus and spleen. Brain Behav. Immun. 7:1993;271-278.
11. Gomariz R.P., Leceta J., Garrido E., Garrido T., Delgado M. Vasoactive intestinal peptide (VIP) mRNA expression in rat T and B lymphocytes. Regul. Peptides. 50:1994;177-184.
12. Leceta J., Martinez M.C., Delgado M., Garrido E., Gomariz R.P. Lymphoid cell subpopulations containing vasoactive intestinal peptide in the rat. Peptides. 15:1994;791-797.
13. Leceta J., Martinez C., Delgado M., Garrido E., Gomariz R.P. Expression of vasoactive intestinal peptide in lymphocytes: a possible endogenous role in the regulation of the immune system. Adv. Neuroimmunol. 6:1996;29-39.
14. 1 receptor gene expression in rat thymocyte subsets. Peptides. 17:1996;803-807.
15. Ottaway C.A., Greenberg G.R. Interaction of VIP with mouse lymphocytes. J. Immunol. 132:1984;417-423.
16. Gomariz R.P., Garrido E., Leceta J., Martinez M.C., Abalo R., Delgado M. Gene expression of VIP receptor in rat lymphocytes. Biochem. Biophys. Res. Commun. 203:1994;1599-1604.
17. Johnson M., McCormack R., Delgado M., Martinez C., Ganea D. Murine T lymphocytes express vasoactive intestinal peptide receptor 1 (VIP-R1) mRNA. J. Neuroimmunol. 68:1996;109-119.
18. Delgado M., Martinez C., Johnson M., Gomariz R.P., Ganea D. Differential expression of vasoactive intestinal peptide receptors 1 and 2 (VIP-R1 and VIPR2) in murine lymphocytes. J. Neuroimmunol. 68:1996;27-38.
19. Xin Z., Tang H., Ganea D. VIP inhibits IL-2 and IL-4 production in murine thymocytes activated via the TCR/CD3 complex. J. Neuroimmunol. 54:1994;59-68.
20. Tang H., Sun D., Xin Z., Ganea D. Downregulation of cytokine expression of murine lymphocytes by PACAP and VIP. Ann. N.Y. Acad. Sci. 805:1996;768-779.
21. Wang H.-Y., Xin Z., Tang H., Ganea D. Vasoactive intestinal peptide inhibits IL-4 production in murine T cells by a post-transcriptional mechanism. J. Immunol. 156:1996;3243-3253.
22. Rothenberg E.V. The development of functionally responsive T cells. Adv. Immunol. 51:1992;85-214.
23. Sant'Angelo D.B., Waterbury G., Preston-Hurlburt P., Yoon S.T., Medzihitov R., Hong S.-C., Janeway C.A. Jr. The specificity and orientation of a TCR to its peptide-MHC class II ligands. Immunity. 4:1996;367-376.
24. Wolf S.D., Dittel B.N., Janeway C.A. Jr. Experimental autoimmune encephalomyelitis induction in genetically B-cell deficient mice. J. Exp. Med. 184:1996;2271-2278.
25. Lamperti E.D., Rosen K.R., Villa-Komaroff L. Characterization of the gene and messages for vasoactive intestinal peptide (VIP) in rat and mouse. Mol. Brain Res. 9:1991;217-231.
26. Inagaki N., Yoshida H., Mizuta M., Gonoi T., Miyazaki J.I., Seino S. Cloning and functional characterization of a third pituitary adenylate cyclase activating peptide receptor subtype expressed in insulin-secreting cells. Proc. Natl. Acad. Sci. 91:1994;2679-2683.
27. Lugo J.P., Krishnan S.N., Diamond Sailor R., Rothenberg E.V. Early precursor thymocytes can produce IL-2 upon stimulation with calcium ionophore and phorbol ester. Proc. Natl. Acad. Sci. USA. 83:1986;1862-1866.
28. Rothenberg E.V., Diamond R.A., Pepper K.A., Yang J.A. IL-2 gene inducibility in T cells before T cell receptor expression. J. Immunol. 144:1990;1614-1624.
29. Fisher M., MacNeil I., Suda T., Cupp J.E., Shortman K., Zlotnik A. Cytokine production by mature and immature thymocytes. J. Immunol. 146:1991;3452-3456.
30. Tang H., Welton A., Ganea D. Neuropeptide regulation of cytokine expression. Effects of VIP and Ro 25-1553. J. Interferon Cytokine Res. 15:1995;993-1003.
31. De la Fuente M., Delgado M., Gomariz R.P. VIP modulation of immune cell functions. Adv. Neuroimmunol. 6:1996;75-95.
32. Ganea D. Regulatory effects of vasoactive intestinal peptide on cytokine production in central and peripheral lymphoid organs. Adv. Neuroimmunol. 6:1996;61-74.
33. Kimata H. Vasoactive intestinal peptide differentially modulates human immunoglobulin production. Adv. Neuroimmunol. 6:1996;107-117.
34. Weinstock J.V. Vasoactive intestinal peptide regulation of granulomatous inflammation in murine Schistosomiasis mansoni. Adv. Neuroimmunol. 6:1996;95-106.
35. Chen D., Rothenberg E.V. Molecular basis for developmental changes in interleukin-2 gene inducibility. Mol. Cell Biol. 13:1993;228-237.
36. Vandekerckhove B.A.E., Barcena A., Schols D., Mohan-Peterson S., Spits H., Roncarolo M.G. In vivo cytokine expression in the thymus. J. Immunol. 152:1994;1738-1743.
37. Xin Z, Sun L, Ganea D. Vasoactive intestinal peptide stimulates p59fyn kinase activity in murine thymocytes. Peptides. In Press.
38. Calvo J.R., Pozo D., Guerrero J.M. Functional and molecular characterization of VIP receptors and signal transduction in human and rodent immune systems. Adv. Neuroimmunol. 6:1996;39-48.
39. Novak T.J., Rothenberg E.V. cAMP inhibits induction of IL-2 but not IL-4 in T cells. Proc. Natl. Acad. Sci. USA. 87:1990;9353-9358.
40. Betz M., Fox B.S. PGE2 inhibits production of TH1 but not TH2 lymphokines. J. Immunol. 146:1991;108-113.
41. Anastassiou E.D., Paliogianni F., Balow J.P., Yamada H., Boumpas D.T. PGE2 and other cAMP elevating agents modulate IL-2 and IL-2Ra gene expression at multiple levels. J. Immunol. 148:1992;2845-2852.
42. Lee H.J., Matsuda I., Naito Y., Yokota T., Arai N., Arai K. Signals and nuclear factors that regulate the expression of IL-4 and IL-5 genes in helper T cells. J. Allergy Clin. Immunol. 94:1994;594-601.
43. + T cells inhibits acquisition of ability to produce IFNy and IL-2, but not IL-4 and IL-5. J. Immunol. 155:1995;4604-4612.
44. Paliogianni F., Kincaid R.L., Boumpas D.T. PGE2 and other cAMP elevating agents inhibit IL-2 gene transcription by counteracting calcineurin-dependent pathways. J. Exp. Med. 178:1993;1813-1818.
45. Borod J., Spetz A.L., Strominger J.L., Habener J.F. cAMP inducibility of transcriptional repressor ICER in developing and mature human T lymphocytes. Proc. Natl. Acad. Sci. USA. 93:1996;3536-3541.
46. Hsueh Y.P., Lai M.-Z. c-Jun N-terminal kinase but not mitogen-activated protein kinase is sensitive to cAMP inhibition in T lymphocytes. J. Biol. Chem. 270:1995;18094-18098.
47. Gourlet P., Vertongen P., Vandermeers A., Vandermeers-Piret M.-C., Rathe P., Waelbroeck M., Robberecht P. The long acting vasoactive intestinal polypeptide agonist RO 25-1553 is highly selective of the VIP2 receptor subclass. Peptides. 18:1997;403-408.
48. Usdin T.B., Bonner T.I., Mezey E. Two receptors for vasoactive intestinal peptide with similar specificity and complementary distributions. Endocrinology. 135:1994;2662-2670.
49. Ernstrom U., Gafvelin G., Mutt V. Rescue of thymocytes from cell death by vasoactive intestinal peptide. Regul. Peptides. 57:1995;99-104.
50. + thymocytes from glucocorticoid-induced apoptosis. Blood. 87:1996;5152-5161.
51. Okumura N., Miyatake Y., Takao T., Nagai K., Okada M., Nakagawa H. Vasoactive intestinal peptide induces differentiation and MAP kinase activation in PC12h cells. J. Biochem. 115:1994;304-308.
52. Anderson S.J., Levin S.D., Perlmutter R.M. Involvement of the protein tyrosine kinase p56lck in T cell signalling and thymocyte development. Adv. Immunol. 56:1994;151-178.
53. Crompton T., Gilmour K.C., Owen M.J. The MAP kinase pathway controls differentiation from double negative to double positive thymocytes. Cell. 86:1996;243-251.
54. + thymocytes. Blood. 87:1996;865-870.
55. Jenkinson E.J., Kingston R., Owen J.J.T. Importance of IL-2 receptors in intra-thymic generation of cells expressing T cell receptors. Nature. 329:1987;160-164.
56. Tentori L., Longo D. L, Zuniga-Pflucker J.C., Wing C., Kruisbeek A.M. Essential role of IL-2 receptor pathway in thymocyte maturation in vivo. J. Exp. Med. 168:1988;1741-1752.
57. Schorle H., Hotschke T., Hunig T., Schimpl A., Horak I. Development and function of T cells in mice rendered IL-2 deficient by gene targeting. Nature. 352:1991;621-624.
58. He W., Kabelitz D. Differential effects of IL-2 and IL-7 on the induction of CD4 and CD8 expression by double negative human thymocytes. Scand. J. Immunol. 41:1995;309-312.
59. Wang Y., Ning Z., Zhang Q. Responses of human fetal splenocytes and thymocytes to IL-2 and comparison with adult peripheral blood lymphocytes. Immunol. Lett. 37:1993;229-233.
60. Brooks C.G., Georgiou A., Jordan R.K. The majority of immature fetal thymocytes can be induced to proliferate to IL-2 and differentiate into cells indistinguishable from mature natural killer cells. J. Immunol. 151:1993;6645-6656.